Risk of Hepatocellular Carcinoma Development in Cases of Hepatitis C Treated by Long-Term, Low-Dose PEG-IFNα-2a

By  

Digestive Diseases, Vol. 30, Iss. 6, 2012-12 ,pp. : 561-567

Karger

Access to resources Recommend Favorite

Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis

By Someya Takashi   Ikeda Kenji   Saitoh Satoshi   Kobayashi Masahiro   Hosaka Tetsuya   Sezaki Hitomi   Akuta Norio   Suzuki Fumitaka   Suzuki Yoshiyuki   Arase Yasuji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1206-1213

Springer Publishing Company

Access to resources Recommend Favorite

Effect of single-dose administration of recombinant interferon-alpha2b on gastric myoelectrical activity in patients with chronic hepatitis C

By Jonderko Krzysztof   Krusiec-Świdergoł Beata   Mazur Włodzimierz   Kasicka-Jonderko Anna   Gonciarz Maciej   Błońska-Fajfrowska Barbara   Gonciarz Zbigniew  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1035-1044

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated progression of hepatocellular carcinoma with cytokeratin 19 expression during treatment with lamivudine for hepatitis B virus-related liver cirrhosis

By Yamada Masayoshi   Shiroeda Hisakazu   Sato Katsuaki   Hayashi Ranji   Nomura Tomoe   Tsutsumi Mikihiro   Arisawa Tomiyasu  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 249-251

Informa Healthcare

Access to resources Recommend Favorite

Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma

By Yin Jianhua   Xie Jiaxin   Zhang Hongwei   Shen Qiuxia   Han Lei   Lu Wenying   Han Yifang   Li Chengzhong   Ni Wu   Wang Hongyang   Cao Guangwen  

Journal of Gastroenterology, Vol. 45, Iss. 10, 2010-10 ,pp. : 1063-1071

Springer Publishing Company

Access to resources Recommend Favorite